Search Results

This blood pressure monitor is intended to be used to measure (systolic and diastolic) and heart rate from the wrist by using the oscillometric method. The device detects the appearance of irregular heartbeats during measurement and gives a symbol with reading. The device is intended for using in only adult population, not applied to the other populations such as neonatal baby. It can't be used while the wrist (arm) has bleeding or wound to avoid the blood flowing from the wound in pressurizing. The wrist circumference is limited to 13.5cm - 21.5cm.

Bluetooth Blood Pressure Monitor, BPW1 is a fully automatic non-invasive blood pressure monitor which measures systolic and diastolic blood pressure and heart rate of adult population using the oscillometric method, including irregular heartbeats (IHB) from the wrist. The device is powered by a rechargeable Lithium battery. The device has an START/STOP button for starting the measurement and stopping the measurement at any time when measuring. The MEM button is for displaying the last measurement. The device can also connect the mobile platform with an MMA (mobile medical application) as its accessory which can start/stop the device through Bluetooth 4.0. An irregular heartbeats rhythm is defined as a rhythm that varies by 25% less or more than the average rhythm detected while the monitor is measuring the systolic and diastolic blood pressure.

The provided text describes the submission of a 510(k) premarket notification for a "Bluetooth Blood Pressure Monitor, BPW1" and its substantial equivalence to a predicate device. It details various performance tests conducted, including safety, EMC, reliability, and biocompatibility. However, it does not contain the specific acceptance criteria for the device's performance (e.g., blood pressure accuracy in mmHg or pulse accuracy in bpm), nor does it provide the detailed study results that prove the device meets these criteria in a quantitative manner.

Instead, the document states that the device was tested according to relevant standards (e.g., IEC 80601-2-30, ISO81060-2:2013) and that it "met all relevant requirements" or "achieved the requirements." It also states "The evaluation of these results present no new issues related to safety or effectiveness." This indicates that the study was performed, and the results were deemed acceptable, but the specific numerical performance data and detailed acceptance thresholds are not included in this summary.

Therefore, for aspects requiring quantitative data (like specific accuracy tolerances and achieved performance), the information is implicitly covered by conformance to standards, but not explicitly stated.

Based on the provided text, here's what can be extracted and what cannot:

1. A table of acceptance criteria and the reported device performance:

Note: The "Accuracy" values (Static Pressure: ± 3mmHg, Pulse: ± 5% reading value) are explicitly stated in the "Comparison of Technological Characteristics" table under the "Accuracy" row for both the predicate and modified device. This implies they are the expected performance standard and likely the acceptance criteria for those specific parameters. The broader "Reported Device Performance" for other categories is a general statement of compliance with standards, as detailed numerical results are not included.

2. Sample sized used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective):
The text clearly mentions "Clinical Validation: ISO81060-2:2013 Non-invasive sphygmomanometers —Part 2: Clinical validation of automated measurement type." This standard specifies requirements for the number of subjects and measurements for clinical validation. While the exact number of subjects is not stated in this document, it implies that the sample size adhered to the ISO 81060-2:2013 standard. The provenance of the data (country of origin, retrospective/prospective) is not explicitly stated in this document.

3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts:
This information is not provided in the document. For a blood pressure monitor, the ground truth for clinical validation is typically established by trained observers using a reference measurement method (e.g., auscultation with a sphygmomanometer). The ISO 81060-2 standard outlines requirements for such observers, but the specific details are not in this text.

4. Adjudication method (e.g. 2+1, 3+1, none) for the test set:
This information is not provided in the document. For blood pressure clinical validation, ground truth primarily relates to the reference measurement method (e.g., mercury sphygmomanometer with trained observers), rather than expert adjudication of AI output.

5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:
This device is a blood pressure monitor, not an AI-based imaging diagnostic tool that typically involves human readers. Therefore, an MRMC study is not applicable and was not performed.

6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done:
Yes, the clinical validation study conducted per ISO 81060-2:2013 is a standalone performance test of the device (its algorithm) against a reference standard. The document states, "The device has achieved the requirements of ISO18060-2:2013," which indicates its standalone performance against a clinical reference.

7. The type of ground truth used (expert consensus, pathology, outcomes data, etc):
For the clinical validation of the blood pressure monitor, the ground truth would be established through simultaneous or closely sequential measurements using a validated reference method, typically auscultation by trained observers with a mercury sphygmomanometer or another precisely calibrated and validated reference device, as specified by ISO 81060-2:2013. This is implicitly the "ground truth" against which the device's measurements are compared.

8. The sample size for the training set:
This device is a traditional oscillometric blood pressure monitor, not a machine learning/AI device requiring a separate "training set" in the conventional sense of AI model development. Therefore, this concept is not applicable in the context presented. The "training" for such devices is inherent in their design and calibration processes, not a distinct data set for algorithm training.

9. How the ground truth for the training set was established:
As explained in point 8, the concept of a separate "training set" with established ground truth as used in AI/ML is not applicable to this type of medical device based on the information provided.

Ask a specific question about this device

BW-BA1 Bluetooth Blood Pressure Monitor is intended to be used to measure systolic and diastolic blood pressure and heart rate from the upper arm with arm circumference ranging from 8.7 inches (approx.22 cm to 42 cm) using the oscillometric method. The device detects the appearance of irregular heartbeats during measurement and gives a "IHB" warning signal with readings. The intended patient population of the device is only adult population aged 18 or older at home, not applied to the other populations such as neonatal baby.

It cannot be used while the arm has bleeding or wound to avoid the blood flowing from the wound in pressurizing. The device cannot be used by pregnant patients or patients suffering from pre-eclampsia.

BW-BA1 Bluetooth Blood Pressure Monitor is a fully automatic non-invasive blood pressure monitor which measures systolic and diastolic blood pressure and heart rate of adult population using the oscillometric method during inflating @ 3~8mmHg/second from about 30mmHg by inflating a cuff on the upper arm. The device detects the appearance of irregular heartbeats during measurement and gives a warning signal with readings. An irregular heartbeat rhythm is defined as rhythm that is 25% less or 25% more than the average rhythm detected while the monitor is measuring the systolic and diastolic blood pressure.

BW-BA1 Bluetooth Blood Pressure Monitor without any display component achieves its function by integrating the device with a collateral device iPhone, iPad with a specific mobile app to constitute a complete blood pressure measurement system. And the new device connects the mobile platform with the mobile app through Bluetooth 4.0.

The operational principle is based on oscillometric and pressure sensor technology, it can calculate the systolic and diastolic blood pressure, and the measurement results can be classified by the function of blood pressure classification indicator according to the classification rule developed by WHO.

The BW-BA1 is powered by a rechargeable Lithium battery.

The device has an ON/START button for starting the measuring and stopping the measuring at any time when measuring.

The provided text describes the 510(k) premarket notification for the BW-BA1 Bluetooth Blood Pressure Monitor. It primarily focuses on demonstrating substantial equivalence to a predicate device rather than providing a detailed clinical study report with acceptance criteria and device performance.

However, based on the information provided and the common requirements for blood pressure monitors, we can infer some details and highlight the missing information.

Here's an attempt to structure the answer based on your request, with a clear indication of what is not explicitly stated in the provided documents:

1. Table of acceptance criteria and the reported device performance

The document does not explicitly present a table of acceptance criteria and reported device performance for blood pressure measurement accuracy. However, it does state the device's accuracy claims and mentions adherence to ISO 81060-2, which dictates such criteria.

Important Note: The document explicitly states: "Clinical validation concerning the compliance of ISO 81060-2 has been performed that the device BW-BA1 is the same as the predicate except IHB adding for our device. And the fundamental scientific technology of the device is identical with the predicate and IHB adding does not raise new questions of safety and effectiveness. Therefore the performance of the device in terms of blood pressure measurement would be identical with performance of the predicate." This implies that the device's performance is expected to meet the same accuracy standards as the predicate device, which would have been demonstrated through its own ISO 81060-2 validation. However, the direct results of this "clinical validation" for the BW-BA1 are not provided in the text.

2. Sample size used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)

The document does not explicitly state the sample size used for the clinical validation or the data provenance. It only mentions that "Clinical validation concerning the compliance of ISO 81060-2 has been performed." For ISO 81060-2, a typical clinical validation would involve an appropriate number of participants (e.g., generally 85 subjects with specific age and blood pressure distributions as per the standard).

3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience)

This information is not provided in the document. For blood pressure monitor validation studies (like those following ISO 81060-2), ground truth is typically established by trained clinical professionals (e.g., physicians, nurses) using auscultatory methods with a mercury sphygmomanometer or validated reference device. The number and qualifications of these experts are usually specified in detailed study protocols, which are not included here.

4. Adjudication method (e.g. 2+1, 3+1, none) for the test set

This information is not provided in the document. For blood pressure validation studies, ground truth measurements often involve multiple observers taking readings to ensure accuracy and minimize bias, with methods for reconciling discrepant readings.

5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

This is not applicable to this device. The BW-BA1 is a medical device for measuring blood pressure, not an AI-assisted diagnostic tool that would involve human readers or image interpretation. Its primary function is to accurately measure blood pressure.

6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done

Yes, implicit in the independent validation of a blood pressure monitor, the device's ability to measure blood pressure accurately standalone (i.e., its algorithm for oscillometric measurement) is evaluated against a reference standard. The document mentions "Clinical validation concerning the compliance of ISO 81060-2 has been performed," which is a standalone validation of the device's measurement accuracy. The output (blood pressure readings) is then displayed via a connected app.

7. The type of ground truth used (expert consensus, pathology, outcomes data, etc)

For blood pressure monitors, the ground truth is typically established by simultaneous measurements taken by trained observers using a calibrated reference device, such as a mercury sphygmomanometer, via the auscultatory method. This involves multiple expert readings to ensure accuracy. The document does not explicitly state this, but it is the standard for ISO 81060-2 compliance.

8. The sample size for the training set

This is not applicable as the BW-BA1 is a traditional blood pressure monitor, not an AI/machine learning-based device that typically uses "training sets" in the same way. Its fundamental operational principle is based on oscillometric and pressure sensor technology.

9. How the ground truth for the training set was established

This is not applicable for the same reasons as #8. The accuracy of oscillometric blood pressure monitors is based on their physical measurement principles and calibration, validated against established clinical methods.

Ask a specific question about this device

Truly Automatic Wrist Bluetooth Blood Pressure Monitor DW702, DW703 are intended to measure the systolic and diastolic blood pressure and pulse rate of an adult individual by using a non-invasive technique in which an inflatable cuff is wrapped around the wrist.

The devices' features include irregular pulse rhythm detection during measurement, and will display an alert signal with the reading when irregular heartbeat is detected.

The devices' features include Bluetooth function to transmit data to an external Bluetooth device with wireless communication.

Truly Automatic Wrist Bluetooth Blood Pressure Monitor DW702, DW703 are designed to measure the systolic and diastolic blood pressure and pulse rate of an individual by using a non-invasive technique in which an inflatable cuff is wrapped around the wrist. Our method to define systolic and diastolic pressure is similar to the auscultatory method but uses an electronic pressure sensor rather than a stethoscope and mercury manometer. The sensor converts tiny alterations in cuff pressure to electrical signals, by analyzing those signals to define the systolic and diastolic blood pressure and calculating pulse rate, which is a well-known technique in the market called the "oscillometric method".

The main components of the Truly Automatic Wrist Blood Pressure Monitor Dw series are the main unit and cuff unit. ABS is used to outer housing of the main unit. The preformed cuff unit, which is applicable to Wrist circumference approximately between 135 and 220 mm, includes the inflatable bladder and nylon shell. All models of the Wrist blood pressure monitor use a single size of cuff. The device consists of the microprocessor, the pressure sensor, the operation keys, the pump, the electromagnetic deflation control valve and the LCD. The subject devices are powered by four AAA alkaline batteries.

The devices also compares the longest and the shortest time intervals of detected pulse waves to mean time interval and displays a warning signal with the reading to indicate the detection of irregular pulse rhythm when the difference of the time intervals is over 25%.

The devices embed a Bluetooth 4.0 Wireless network connections module that allows it to connect to nearby receiving end. Once measurement is over, the LCD of device displays results, and the device will start to send out data such as systolic, diastolic, pulse, date, time with Wireless method and protocol.

Here's the breakdown of the acceptance criteria and study information for the "Automatic Wrist Bluetooth Blood Pressure Monitor" based on the provided text:

1. Table of Acceptance Criteria and Reported Device Performance

2. Sample Size and Data Provenance

• Test Set Sample Size: 85 subjects.
• Data Provenance: The study was conducted "in the hospital," with no specific country of origin mentioned. It appears to be a prospective study given the description of subjects participating in a clinical study.

3. Number of Experts and Qualifications for Ground Truth

• Number of Experts: Two doctors.
• Qualifications of Experts: Not explicitly stated, only referred to as "two doctors." It is implied they are qualified to perform simultaneous and blinded blood pressure determinations using a standard mercury sphygmomanometer.

4. Adjudication Method

• The text states: "Simultaneous and blinded blood pressure determinations were performed by two doctors." This suggests a method where two independent readings were taken, but it doesn't specify if there was a formal adjudication process (e.g., 2+1, 3+1) if their readings differed. It implies an agreement or average was used, but no explicit adjudication method is detailed.

5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study

• No, a Multi-Reader Multi-Case (MRMC) comparative effectiveness study was not explicitly described. The study focused on comparing the device's measurements against a reference standard (mercury sphygmomanometer) performed by human experts, not on comparing human readers' performance with and without AI assistance.

6. Standalone (Algorithm Only) Performance Study

• Yes, a standalone performance study was done. The entire clinical study described aims to demonstrate the accuracy of the device's algorithm in measuring blood pressure and pulse rate without human intervention in the actual measurement process (beyond applying the cuff and initiating the device). The device itself performs the measurement and provides the readings.

7. Type of Ground Truth Used

• The ground truth used was expert consensus / reference standard measurements. Specifically, the ground truth was established by "a standard mercury sphygmomanometer" with "simultaneous and blinded blood pressure determinations" performed by two doctors.

8. Sample Size for the Training Set

• The document does not provide any information regarding the sample size used for the training set. This submission is for a 510(k) premarket notification, which often focuses on clinical validation using existing technology (oscillometric method) rather than detailing the machine learning aspects of an AI algorithm from scratch.

9. How Ground Truth for the Training Set Was Established

• As the document does not provide information on a training set, it does not describe how ground truth for a training set was established. The oscillometric method is a well-established technique described as "a well-known technique in the market." The device is an "upgraded version to include the Bluetooth 4.0 Wireless function" of a previous device. The clinical study serves to validate the performance of the device against a known standard.

Ask a specific question about this device

BW-BW1 Bluetooth Blood Pressure Monitor is intended to measure blood pressure (systolic and diastolic) and heart rate from the wrist using the oscillometric method, the measured data is transferred to a smart phone for the patient record archiving and/or measured data analysis purpose.

The device is intended for use in only adult population, not applied to the other populations such as neonatal baby.

It can not be used while the wrist (arm) has bleeding or wound the blood flowing from the wound in pressurizing.

Not Found

This document is a 510(k) premarket notification for the BW-BW1 Bluetooth Blood Pressure Monitor. It primarily consists of regulatory correspondence and an "Indications for Use" statement, and does not contain the detailed study information needed to answer the request.

Therefore, I cannot provide the requested information about acceptance criteria and the study that proves the device meets them, because this document does not include that data. This document only states that the device is "substantially equivalent" to predicate devices, which is part of the regulatory approval process but doesn't detail performance studies.

Ask a specific question about this device

Truly Automatic Arm Bluetooth Blood Pressure Monitor DB series, Models DB62, DB63, DB85 are a series devices intended to measure the systolic and diastolic blood pressure and pulse rate of an adult individual by using a non-invasive technique in which an inflatable cuff is wrapped around the upper arm.

The devices' features include irregular pulse rhythm detection during measurement, and will display a alert signal with the reading when irregular heartbeat is detected.

The devices' feature include Bluetooth function to transmit data to an external Bluetooth device with wireless communication.

Truly Automatic Arm Bluetooth Blood Pressure Monitor DB series, Models DB62, DB63, DB85 are designed to measure the systolic and diastolic blood pressure and pulse rate of an individual by using a non-invasive technique in which an inflatable cuff is wrapped around the upper arm. Our method to define systolic and diastolic pressure is similar to the auscultatory method but uses an electronic pressure sensor rather than a stethoscope and mercury manometer. The sensor converts tiny alterations in cuff pressure to electrical signals, by analyzing those signals to define the systolic and diastolic blood pressure and calculating pulse rate, which is a well-known technique in the market called the "oscillometric method".

The main components of the Truly Automatic Arm Blood Pressure Monitor DB series are the main unit and cuff unit. ABS is used to outer housing of the main unit. The preformed cuff unit, which is applicable to arm circumference approximately between 220 and 340 mm, includes the inflatable bladder and nylon shell. All models of the arm blood pressure monitor use a single size of cuff. The device consists of the microprocessor, the pressure sensor, the operation keys, the pump, the electromagnetic deflation control valve and the LCD. The subject devices are powered by four AA alkaline batteries.

The devices also compares the longest and the shortest time intervals of detected pulse waves to mean time interval and displays a warning signal with the reading to indicate the detection of irregular pulse rhythm when the difference of the time intervals is over 25%.

The devices embed a Bluetooth 4.0 Wireless network connections module that allows it to connect to nearby receiving end. Once measurement is over, the LCD of device displays results, and the device will start to send out data such as systolic, diastolic, pulse, date, time with Wireless method and protocol.

Here's a breakdown of the acceptance criteria and the study that proves the device meets them, based on the provided text:

Device Name: Automatic Arm Bluetooth Blood Pressure Monitor (Models DB62, DB63, DB85)

1. Table of Acceptance Criteria and Reported Device Performance

The acceptance criteria are derived from the ISO81060-2 Standard. The reported device performance refers to the results of the clinical study.

Note on Criterion 2: The document provides a table for Maximum permissible standard deviation, Sm, as a function of mean error, xn. The reported Std for Criterion 2 (2.56 mmHg for systolic and 2.10 mmHg for diastolic) would need to be compared against the values in this table based on the reported mean errors (2.5 mmHg for systolic and 1.8 mmHg for diastolic) to explicitly confirm conformance. However, the study directly states, "Through clinical research, we can convinced that the clinical device is safe and effective," implying these values met the standard.

2. Sample Size Used for the Test Set and Data Provenance

• Sample Size: 85 subjects.
• Data Provenance: The clinical study was conducted in a hospital. This suggests prospective data collection in a clinical setting, likely in the country of origin of the manufacturer (China), though not explicitly stated.

3. Number of Experts Used to Establish Ground Truth and Qualifications

• Number of Experts: Two doctors.
• Qualifications of Experts: The document states "Simultaneous and blinded blood pressure determinations were performed by two doctors." Their specific qualifications (e.g., years of experience, specialization) are not detailed beyond "doctors."

4. Adjudication Method for the Test Set

• Adjudication Method: Implicitly, a simultaneous and blinded comparison against a standard mercury sphygmomanometer (reference standard) with two doctors performing the determinations. This suggests that the readings from the two doctors on the reference standard formed a consensus or averaged ground truth against which the device was compared. The document does not specify a formal adjudication process like "2+1" or "3+1" for resolving discrepancies between the two doctors, but rather implies their measurements constituted the reference.

5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study

• Was a MRMC study done? No, a MRMC comparative effectiveness study was not done. The study focused on the accuracy of the device against a gold standard, not on how human readers' performance improved with or without AI assistance.

6. Standalone Performance Study

• Was a standalone study done? Yes, the clinical study performed was a standalone study of the algorithm's performance. The device itself (Automatic Arm Bluetooth Blood Pressure Monitor) is the "algorithm only" in this context, as it automatically measures and displays blood pressure readings without a human-in-the-loop directly interpreting raw signals. Its performance was measured against the reference standard.

7. Type of Ground Truth Used

• Type of Ground Truth: The ground truth was established using a standard mercury sphygmomanometer as a reference standard, with simultaneous and blinded blood pressure determinations performed by two doctors. This is a form of expert consensus/reference measurement, widely accepted for blood pressure monitor validation.

8. Sample Size for the Training Set

• Sample Size for Training Set: The document does not provide information regarding a specific training set or its sample size. This is common for devices that use established physiological measurement principles (like the oscillometric method for blood pressure) rather than complex machine learning models that require explicit training on large datasets for regulatory submission. The "oscillometric method" itself is a well-known technique.

9. How the Ground Truth for the Training Set Was Established

• How Ground Truth for Training Set Was Established: As no specific training set is mentioned, the method for establishing its ground truth is not applicable/not provided in this document. The device operates based on the "oscillometric method," which is a pre-established principle rather than a continuously learning algorithm requiring a dedicated, labeled training set like many AI/ML devices.

Ask a specific question about this device

The AViTA Bluetooth Blood Pressure Monitor (Model no.: BPM656ZB) is intended to measure the blood pressure (systolic and diastolic) and pulse rate by oscillometric method. The measurements are conducted by using an cuff which is wrapped around the upper arm. At the end of each measurement, the results will be displayed on LCD. AViTA BPM656ZB through its Bluetooth wireless communication port can also transfer the measurement results to other electronic devices, such as a PC , a PDA or a printer.

The device is indicated for adult in home use. The arm circumference range shall be between 9 inches (23 cm) to 17 inches (43 cm). The end users should not have common arrhythmias, such as atrial or ventricular premature beats or atrial fibrillation.

The AViTA Bluetooth Blood Pressure Monitor (Model no.: BPM656ZB) is designed to measure the systolic and diastolic blood pressure, and pulse rate (heart of an individual).

The device uses an inflated cuff which is wrapped around the upper arm. The cuff is inflated by an electrical air pump. The systolic and diastolic blood pressures are determined by oscillometric method. The deflation rate is controlled by a preset mechanical valve at a constant rate. At any moment of measurement, the user can deflate the cuff. The measurement results are displayed on the LCD and transmitted to a Bluetooth enabled devices, such as a PC, a PDA, a printer, or and access point.

The provided text describes a 510(k) submission for the AViTA Bluetooth Blood Pressure Monitor. However, it does not contain the specific information required to complete the detailed acceptance criteria and study analysis table as requested.

The document primarily focuses on:

• Identifying the submitter and device.
• Classifying the device and its predicate.
• Stating the intended use.
• Giving a brief device description.
• Concluding that the device is substantially equivalent to the predicate based on intended use, technological characteristics, and bench testing (without detailing the bench testing results or criteria).
• The FDA's official acceptance letter.

Therefore, many of the requested fields cannot be filled from the provided text.

Here's a response based on the available information, with explanations for what is missing:

Acceptance Criteria and Device Performance Study Analysis

The provided 510(k) summary for the AViTA Bluetooth Blood Pressure Monitor (Model no.: BPM656ZB) states that the device conforms to applicable standards, including EN-1060-1, EN-1060-3, and ANSI/AAMI SP-10. These standards define the acceptance criteria for non-invasive sphygmomanometers. However, the specific reported device performance against these criteria is not detailed in the provided document. The 510(k) simply concludes that "bench testing contained in this submission demonstrate that any differences in their technological characteristics do not raise any new questions of safety or effectiveness."

1. Table of Acceptance Criteria and Reported Device Performance

2. Sample size used for the test set and the data provenance:

• Sample Size for Test Set: Not specified in the provided text.
• Data Provenance: Not specified (e.g., country of origin, retrospective or prospective). The text only mentions "bench testing contained in this submission" as the basis for performance claims.

3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts:

• Number of Experts: Not specified.
• Qualifications of Experts: Not specified. For blood pressure devices, reference measurements are typically taken by trained technicians, often using auscultation with a calibrated mercury or aneroid sphygmomanometer, according to standard protocols (e.g., AAMI/ISO standards). The "ground truth" for blood pressure accuracy studies is usually these simultaneous, expert-performed reference measurements.

4. Adjudication method (e.g., 2+1, 3+1, none) for the test set:

• Adjudication Method: Not specified. This typically refers to how discrepancies in expert readings are resolved, which would be relevant if multiple experts were performing initial ground truth measurements.

5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:

• MRMC Study: No, this is not applicable for a standalone blood pressure monitor. MRMC studies are typically for image analysis or diagnostic support systems where human readers interpret data with or without AI assistance. This device simply provides blood pressure readings.

6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done:

• Standalone Performance: Yes, the device operates in a standalone mode, measuring and displaying blood pressure and heart rate. The performance indicated by conformance to standards like ANSI/AAMI SP-10 refers to the algorithm's accuracy in determining blood pressure from the oscillometric pulsations, without human interpretation of the underlying data.

7. The type of ground truth used (expert consensus, pathology, outcomes data, etc.):

• Type of Ground Truth: Most likely, the ground truth for accuracy testing would be simultaneous, highly accurate measurements performed by a trained observer using a validated reference method (e.g., auscultatory measurements by a trained observer using a mercury sphygmomanometer) in accordance with the relevant international standards (e.g., ANSI/AAMI SP-10, ISO 81060-2). The expert's reading acts as the comparator.

8. The sample size for the training set:

• Sample Size for Training Set: Not applicable/Not specified. For a traditional oscillometric blood pressure monitor, there isn't a "training set" in the machine learning sense. The device's algorithm is based on physiological principles and pre-defined mathematical models, rather than being "trained" on a dataset. The development and calibration would involve engineering and clinical validation rather than machine learning training.

9. How the ground truth for the training set was established:

• Ground Truth for Training Set: Not applicable. As mentioned above, there isn't a training set in the machine learning context for this type of device. The algorithm's fundamental principles are established through engineering design and physiological understanding.

Ask a specific question about this device